The DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Oxygen Radical-Mediated Pulmonary Toxicity Induced by Some Cationic Liposomes
Abstract
Purpose The objectives of this study are to investigate the toxicity associated with polycationic liposomes and to elucidate the underlying mechanism. We tested the hypothesis that the positive charge of liposomes is a key determinant of toxicity by testing differently charged liposomes in mice.Methods Differently charged liposomal systems including cationic liposomes, LipofectAMINE and DOTAP, and neutral and negative liposomes were evaluated for their toxicity after pulmonary administration in mice. LDH assay and differential cell counts were performed to measure toxicity and pulmonary inflammation, respectively. Reactive oxygen intermediates (ROI) were assessed by chemiluminescence.Results Instillation of cationic liposomes elicited dose-dependent toxicity and pulmonary inflammation. This effect was more pronounced with the multivalent cationic liposome LipofectAMINE as compared to the monovalent cationic DOTAP. Neutral and negative liposomes did not exhibit lung toxicity. Toxicity associated with cationic liposomes correlated with the oxidative burst induced by the liposomes. LipofectAMINE induced a dose-dependent increase in ROI generation. This effect was less pronounced with DOTAP and absent with neutral and negative liposomes.Conclusions ROI play a key role in cationic lipid-mediated toxicity. Polyvalent cationic liposomes cause a release of ROI which are responsible for the pulmonary toxicity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Cationic and ionizable lipids have also been reported to stimulate the secretion of pro-inflammatory cytokines and reactive oxygen species170–173.”
From Lipid nanoparticles for mRNA delivery (2021) · cites this paper as [171]
Citations
Cites
Nabel, G. J., Nabel, E. G., Yang, Z., Fox, B. A., Plautz, G. E., Gao, X., Huang, L., Shu, S., Gordon, D., & Chang, A. E. (1993) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.90.23.11307 · Cited by 882
A novel cationic liposome reagent for efficient transfection of mammalian cells
Gao, X., & Huang, L. (1991) · Biochemical and Biophysical Research Communications · doi:10.1016/0006-291x(91)91366-k · Cited by 847
Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosis
Caplen, N. J., Alton, E. W. F. W., Mddleton, P. G., Dorin, J. R., Stevenson, B. J., Gao, X., Durham, S. R., Jeffery, P. K., Hodson, M. E., Coutelle, C. C., et al. (1995) · Nature Medicine · doi:10.1038/nm0195-39 · Cited by 710
Cationic liposome-mediated gene transfer.
Gao, X., & Huang, L. (1995) · PubMed · Cited by 619
Characterization of Cationic Liposome-Mediated Gene Transfer In Vivo by Intravenous Administration
Song, Y. K., Liu, F., Chu, S., & Liu, D. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.13-1585 · Cited by 297
Scheule, R. K., George, J. A. S., Bagley, R. G., Marshall, J., Kaplan, J. M., Akita, G. Y., Wang, K. X., Lee, E. R., Harris, D. J., Jiang, C., et al. (1997) · Human Gene Therapy · doi:10.1089/hum.1997.8.6-689 · Cited by 251
Brigham, K. L., Meyrick, B. O., Christman, B. W., Magnuson, M. A., King, G. A., & Berry, L. C. (1989) · The American Journal of the Medical Sciences · doi:10.1097/00000441-198910000-00013 · Cited by 201
Guanidinium-cholesterol cationic lipids: efficient vectors for the transfection of eukaryotic cells.
Vigneron, J., Oudrhiri, N., Fauquet, M., Vergely, L., Bradley, J., Basseville, M., Lehn, P., & Lehn, J. (1996) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.93.18.9682 · Cited by 200
Freimark, B. D., Blezinger, H. P., Florack, V. J., Nordstrom, J. L., Long, S. D., Deshpande, D., Nochumson, S., & Petrak, K. (1998) · The Journal of Immunology · doi:10.4049/jimmunol.160.9.4580 · Cited by 178
Gossart, S., Cambon, C., Orfila, C., Séguélas, M., Lepert, J., RAMI, J., Carré, P., & Pipy, B. (1996) · The Journal of Immunology · doi:10.4049/jimmunol.156.4.1540 · Cited by 163
Research works printed but not linked: 1
- P. Hawley-Nelson, V. Ciccarone, G. Gebeyehu, and J. Jessee. Lipofectamine reagent: A new, higher efficiency polycationic liposome transfection reagent. Focus 15:73–79 (1993).
Cited by
Sorted by citations
Items 201–300 of 349
Jampílek, J., & Kráľová, K. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-46152-8.00002-0 · Cited by 20
RNA interference in immune cells by use of osmotic delivery of siRNA
Aoki, M., Ishii, T., Kanaoka, M., & Kimura, T. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.12.191 · Cited by 20
Thakor, D. K., Teng, Y. D., Obata, H., Nagane, K., Saito, S., & Tabata, Y. (2010) · Tissue Engineering Part C Methods · doi:10.1089/ten.tec.2010.0120 · Cited by 19
Cardiovascular therapy through nanotechnology – how far are we still from bedside?
Cicha, I., Garlichs, C. D., & Alexiou, C. (2014) · European Journal of Nanomedicine · doi:10.1515/ejnm-2014-0001 · Cited by 19
“Those characteristics should thus be considered when designing liposome-based drug-delivery systems in order to minimize the potential side effects (149, 157).”
BackgroundImproving the Repeatability and Efficacy of Intradermal Electroporated Self-Replicating mRNA
Huysmans, H., Temmerman, J. D., Zhong, Z., Cafferty, S. M., Combes, F., Haesebrouck, F., & Sanders, N. N. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.06.011 · Cited by 19
Chen, H.-C. G., Chiou, S.-T., Zheng, J.-Y., Yang, S.-H., Lai, S., & Kuo, T. (2011) · Archives of Virology · doi:10.1007/s00705-011-0920-4 · Cited by 19
“But in vivo, its toxicity [21, 66] leads to counterproductive results (Fig. 5). Cationic liposomes can be inactivated by pulmonary surfactants [16] and serum proteins [2] and can cause cytotoxic reactions such as pulmonary inflammation [60], antiproliferative activity in proteoglycan-deficient cells [5], production of…”
BackgroundCationic liposomes containing antioxidants reduces pulmonary injury in experimental model of sepsis
Galvão, A. M., Galvão, J. S., Pereira, M. A., Cadena, P. G., Santos-Magalhães, N. S., Fink, J. B., de Andrade, A. D., de Castro, C. M. M. B., & Maia, M. B. D. S. (2016) · Respiratory Physiology & Neurobiology · doi:10.1016/j.resp.2016.06.001 · Cited by 19
Highly efficient siRNA transfection in macrophages using apoptotic body-mimic Ca-PS lipopolyplex
Lai, Y., Xu, X., Zhu, Z., & Hua, Z. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s176991 · Cited by 19
“11–18 Among these hard-to-transfect cells, macrophages are notoriously difficult to transfect using liposomes and, therefore, are usually genetically manipulated using viral vectors; but, preparation of these viral vectors could be challenging and presents biosafety threats to researchers.”
Ihara, D., Hattori, N., Horimasu, Y., Masuda, T., Nakashima, T., Senoo, T., Iwamoto, H., Fujitaka, K., Okamoto, H., & Kohno, N. (2015) · Pharmaceutical Research · doi:10.1007/s11095-015-1747-6 · Cited by 19
Cun, D., Wan, F., & Yang, M. (2015) · Current Pharmaceutical Design · doi:10.2174/1381612821666150416100800 · Cited by 17
Recent Progresses in Organic-Inorganic Nano Technological Platforms for Cancer Therapeutics
Kumar, S., Singhal, A., Narang, U., Mishra, S., & Kumari, P. (2018) · Current Medicinal Chemistry · doi:10.2174/0929867326666181224143734 · Cited by 17
Methods for CRISPR-Cas as Ribonucleoprotein Complex Delivery In Vivo
Bykonya, A. G., Лавров, А. В., & Smirnikhina, S. (2022) · Molecular Biotechnology · doi:10.1007/s12033-022-00479-z · Cited by 17
Anti-EGFR immunonanoparticles containing IL12 and salmosin genes for targeted cancer gene therapy
Kim, J. S., Kang, S. J., Jeong, H. Y., Kim, M. W., Park, S. I., Lee, Y. K., Kim, H. S., Kim, K. S., & Park, Y. S. (2016) · International Journal of Oncology · doi:10.3892/ijo.2016.3619 · Cited by 16
Inhalation of Respirable Crystalline Rifapentine Particles Induces Pulmonary Inflammation
Parumasivam, T., Ashhurst, A. S., Nagalingam, G., Britton, W. J., & Chan, H. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00905 · Cited by 16
Rani, N. N. I. M., Hussein, Z. M., Mustapa, F., Azhari, H., Sekar, M., Chen, X. Y., & Amin, M. C. I. M. (2021) · European Journal of Pharmaceutics and Biopharmaceutics · doi:10.1016/j.ejpb.2021.04.021 · Cited by 17
Next-generation poly-L-histidine formulations for miRNA mimic delivery
Kasina, V., Wahane, A. V., Liu, C., Yang, L., Nieh, M., Slack, F. J., & Bahal, R. (2023) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2023.03.015 · Cited by 15
“Although we used Lipofectamine for the comparative analysis, it is challenging to perform the in vivo studies with Lipofectamine due to the side effects associated with its lipid content.(26)”
MethodTung, J., Tew, L. S., Hsu, Y., & Khung, Y. L. (2017) · Scientific Reports · doi:10.1038/s41598-017-00912-3 · Cited by 15
Hanafy, M. S., Dao, H. M., Xu, H., Koleng, J. J., Sakran, W., & Cui, Z. (2023) · International Journal of Pharmaceutics X · doi:10.1016/j.ijpx.2023.100197 · Cited by 14
“DOTAP has dose-dependent toxicity (Dokka et al., 2000; Jensen et al., 2012); it was reported that increasing DOTAP content in lipid particles is associated with a corresponding increase in the toxicity and proinflammatory activity of the lipid particles in vitro and in vivo (Bian et al., 2012;…”
BackgroundRecent Advances in Messenger Ribonucleic Acid (mRNA) Vaccines and Their Delivery Systems: A Review
Belay, W. Y., Nibret, G., & Aschale, Y. (2023) · Clinical Pharmacology Advances and Applications · doi:10.2147/cpaa.s418314 · Cited by 16
“In addition, rodents have been shown to suffer liver and lung damage as a result of LNP administration in vivo,(106,107) which could be explained by the delivery of LNP materials’ cytotoxicity and the production of pro-inflammatory factors.(108,109)”
Pulmonary Delivery of Peptides and Proteins
Kwok, P. C. L., & Chan, H. (2011) · Elsevier eBooks · doi:10.1016/b978-0-12-384935-9.10002-1 · Cited by 14
Therapeutic Potentials of Noncoding RNAs: Targeted Delivery of ncRNAs in Cancer Cells
Liu, Y., & Wang, J. (2016) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-1498-7_16 · Cited by 14
Sustainable Nanotechnology: Mycotoxin Detection and Protection
Thipe, V. C., Keyster, M., & Katti, K. V. (2018) · Nanotechnology in the life sciences · doi:10.1007/978-3-319-91161-8_12 · Cited by 14
Wardwell, P. R., & Bader, R. A. (2014) · Journal of Biomedical Materials Research Part A · doi:10.1002/jbm.a.35296 · Cited by 14
Emeto, T. I., Alele, F. O., Smith, A. M., Smith, F. M., Dougan, T., & Golledge, J. (2017) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2017.00016 · Cited by 14
“Cationic liposomal NPs can interact with lipoproteins, serum proteins, and ECM, resulting in aggregation and oxidative stress with consequent non-target tissue damage (75, 76).”
BackgroundTelomerase mRNA Enhances Human Skin Engraftment for Wound Healing
Chang, D. F., Court, K. A., Holgate, R., Olmsted‐Davis, E. A., Bush, K., Quick, A. P., Spiegel, A. J., Rahimi, M., Cooke, J. P., & Godin, B. (2023) · Advanced Healthcare Materials · doi:10.1002/adhm.202302029 · Cited by 14
Wang, S., Guo, B., Wang, H., & Yang, F. (2024) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2024.105547 · Cited by 14
‘Smart‘ non-viral Delivery Systems for Targeted Delivery of RNAi to the Lungs
Ramsey, J. M., Hibbitts, A., Barlow, J. W., Kelly, C., Sivadas, N., & Cryan, S. (2012) · Therapeutic Delivery · doi:10.4155/tde.12.133 · Cited by 13
“11 these lipids had previously resulted in adverse effects such as inflammation and toxicity [41].”
BackgroundPérez, S. E., Gándola, Y. B., Carlucci, A. M., González, L., Turyn, D., & Bregni, C. (2012) · Journal of Drug Delivery · doi:10.1155/2012/986265 · Cited by 13
“The ideal in vivo delivery system for siRNA is expected to provide robust gene silencing, be biocompatible, biodegradable and nonimmunogenic, and bypass rapid hepatic or renal clearance.”
BackgroundLewicki, S., Leśniak, M., Machaj, E. K., Antos-Bielska, M., Trafny, E. A., Kocik, J., & Pojda, Z. (2017) · Journal of Liposome Research · doi:10.3109/08982104.2016.1166510 · Cited by 13
“Similarly Dokka et al. (2000) in mice model have shown that cationic liposomes toxicity is generated by oxidative burst and reactive oxygen intermediates generation.”
BackgroundDiacylglycerol in Cationic Nanoparticles Stimulates Oxidative Stress‐Mediated Death of Cancer Cells
Bae, C., & Ahn, T. (2018) · Lipids · doi:10.1002/lipd.12124 · Cited by 12
Various carrier system(s)- mediated genetic vaccination strategies against malaria - Retracted
Tyagi, R. K., Sharma, P., Vyas, S. P., & Mehta, A. (2008) · Expert Review of Vaccines · doi:10.1586/14760584.7.4.499 · Cited by 13
RetractedMohammadabadi, M., El-Tamimy, M., Gianello, R., & Mozafari, M. R. (2009) · Journal of Liposome Research · doi:10.1080/08982100802547326 · Cited by 12
“Moreover, there are reports on the toxicity and other complications associated with the cationic vectors (Dokka et al., 2000; Nagahiro et al., 2000; Omidi et al., 2005).”
BackgroundMethodStueckle, T. A., White, A., Wagner, A., Gupta, R. K., Rojanasakul, Y., & Dinu, C. Z. (2019) · Chemical Research in Toxicology · doi:10.1021/acs.chemrestox.9b00277 · Cited by 12
Self-citationBorowik, T., Widerak, K., Ugorski, M., & Langner, M. (2005) · Journal of Liposome Research · doi:10.1080/08982100500364370 · Cited by 12
Peng, L., Gao, Y., Xue, Y., Huang, S., & Zhuo, R. (2013) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911513481893 · Cited by 12
Wang, X. T., Avanessian, B. K., Ma, Q., Durfee, H., Tang, Y. Q., & Liu, P. Y. (2011) · Wound Repair and Regeneration · doi:10.1111/j.1524-475x.2011.00705.x · Cited by 12
Jeong, H. Y., Kang, S. J., Kim, M. W., Jeong, I., Choi, M. J., Jung, C., Song, I. H., Lee, T. S., & Park, Y. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25031813 · Cited by 11
“Alternatively, neutral liposomes and various drug-capture technologies have been developed [11,21,25–28].”
BackgroundYu, J., Chen, J., Zhao, H., Gao, J., Li, Y., Li, Y., Xue, J., Dahan, A., Sun, D., Zhang, G., et al. (2018) · Molecular Omics · doi:10.1039/c8mo00132d · Cited by 11
Anionic liposomes prepared without organic solvents for effective siRNA delivery
Han, X., Lu, Y., Xu, Z., Chu, Y., Ma, X., Wu, H., Zou, B., & Zhou, G. (2023) · IET Nanobiotechnology · doi:10.1049/nbt2.12117 · Cited by 11
“Anionic liposomes, which are composed of physiologically safe lipids and have a negative charge are a safer alternative to cationic liposomes [9, 13].”
BackgroundDevelopment of TMTP-1 targeted designer biopolymers for gene delivery to prostate cancer
McBride, J. W., Massey, A. S., McCaffrey, J., McCrudden, C. M., Coulter, J. A., Dunne, N., Robson, T., & McCarthy, H. O. (2016) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2016.01.039 · Cited by 11
“Many liposome formulations, for example Lipofectamine 2000, impact on cellular processes including cell cycle control, apoptosis, cellular metabolism, and contribute to cytokine production, pore formation, and cell lysis (Dokka et al., 2000; Fiszer-Kierzkowska et al., 2011; Nguyen et al., 2007).”
BackgroundInteraction of DNA with likely-charged lipid monolayers: An experimental study
Luque‐Caballero, G., Maldonado‐Valderrama, J., Pérez, M. Q., & Martín‐Molina, A. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.02.058 · Cited by 11
Applications and challenges of biomaterial mediated mRNA delivery
Fang, H., & Chen, Q. (2022) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2022.00093 · Cited by 12
Kim, J., Shin, E., Ryou, S.-M., Yeom, J., & Lee, K. (2013) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-012-0546-8 · Cited by 11
“Inflammatory reactions caused by liposomes are another disadvantage [58].”
BackgroundLiposomes: Design and Manufacturing
Patil, S. D., & Burgess, D. J. (2005) · CRC Press eBooks · doi:10.1201/9780849350610-12 · Cited by 11
Müllertz, O. A. O., Andersen, P. L., Christensen, D., Foged, C., & Thakur, A. (2022) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.2c00634 · Cited by 10
du Preez, H. N., Lin, J., Maguire, G. E. M., Aldous, C. M., & Kruger, H. G. (2024) · European Journal of Clinical Investigation · doi:10.1111/eci.14296 · Cited by 12
“63 In a mouse nucleoside-modified mRNA vaccine study, it was confirmed that LNPs are highly inflammatory, independent of the delivery route, evidenced by excessive neutrophil infiltration, activation of various inflammatory pathways and production of various inflammatory cytokines and chemokines.”
InfluentialAdvancements in nanotheranostics for glioma therapy
Sahoo, L., Paikray, S. K., Tripathy, N. S., Fernandes, D. A., & Dilnawaz, F. (2024) · Naunyn-Schmiedeberg s Archives of Pharmacology · doi:10.1007/s00210-024-03559-w · Cited by 12
“Cationic lipids such as DOTAP are more easily attracted to serum proteins, leading to aggregation (Dokka et al. 2000; Lv et al. 2006).”
Supramolecular Assembly Models of siRNA Delivery Systems
Sun, J., Wang, J., & Yang, Z. (2014) · Chinese Journal of Chemistry · doi:10.1002/cjoc.201400484 · Cited by 10
Pulmonary Anti-inflammatory Effects of Chitosan Microparticles Containing Betamethasone
Huang, Y., Vieira, A. V., Yeh, M.-K., & Chiang, C. ‐. (2006) · Journal of Bioactive and Compatible Polymers · doi:10.1177/0883911506073639 · Cited by 10
The Promising Therapeutic Potential of Oligonucleotides for Pulmonary Fibrotic Diseases
Paul, D., Miller, M. H., Born, J. R., Samaddar, S., Ni, H., Avila, H., Krishnamurthy, V. R., & Thirunavukkarasu, K. (2022) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2023.2160439 · Cited by 9
“Compared to their neutral counterparts, cationic LNPs result in higher toxicity due to their ROS generation [93], contribute to an enhanced interferon response [94], and can attenuate or intensify the intended siRNA therapeutic effect [95,96].”
BackgroundDelivery of cationic quantum dots using fusogenic liposomes in living cells
Matos, A. L. L., Pereira, G., Filho, P. E. C., Santos, B. S., & Fontes, A. (2017) · Journal of Photochemistry and Photobiology B Biology · doi:10.1016/j.jphotobiol.2017.04.025 · Cited by 9
“This was caused by the larger quantity of positive lipids (DOTAP) interacting with RBCs, which destabilize their membranes for release the liposome cargo [26, 27].”
BackgroundFalkowski, M., Kucińska, M., Piskorz, J., Wieczorek-Szweda, E., Popenda, Ł., Jurga, S., Sikora, A., Młynarczyk, D. T., Murias, M., Marszałł, M. P., et al. (2020) · Journal of Photochemistry and Photobiology A Chemistry · doi:10.1016/j.jphotochem.2020.112964 · Cited by 9
Non-viral siRNA and shRNA Delivery Systems in Cancer Therapy
Şalva, E., Ekentok, C., Turan, S. Ö., & Akbuğa, J. (2016) · InTech eBooks · doi:10.5772/62826 · Cited by 9
“Interferon responses can lead to not only change in gene expression but also show dosedependent cytotoxicity and pulmonary inflammation [80, 81].”
BackgroundToxicity Concerns of Nanocarriers
Tavakol, S., Kiani, V., Tavakol, B., Derakhshan, M. A., Joghataei, M. T., & Rezayat, S. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809717-5.00016-6 · Cited by 9
Nanotoxicological profiles of clinically approved nanoplatforms
Nkanga, C. I. (2023) · Beni-Suef University Journal of Basic and Applied Sciences · doi:10.1186/s43088-023-00458-6 · Cited by 9
“As an example, through generation of reactive oxygen species, polycationic liposomes (Lipofectamine ™ ) exhibited much higher lung toxicity than monocationic liposomes made of 1,2-dioleoyl-3-trimethylammonium-pro-pane (DOTAP) [32].”
BackgroundMicroneedle-Mediated Delivery of siRNA via Liposomal-Based Transfection for Inner Ear Gene Therapy
Feng, S. J., Voruz, F., Leong, S., Hammer, D. R., Breil, E., Aksit, A., Yu, M., Chiriboga, L. A., Olson, E. S., Kysar, J. W., et al. (2024) · Otology & Neurotology · doi:10.1097/mao.0000000000004297 · Cited by 8
Dry powder inhalation of siRNA therapeutics: Emerging strategies for pulmonary gene silencing
Lu, Y., Zhao, M., Li, M., Liu, N., Wang, Z., Zhang, H., Duan, S., Wu, J., & Zheng, A. (2025) · Journal of Pharmaceutical Sciences · doi:10.1016/j.xphs.2025.104076 · Cited by 9
Singh, N. K., Singh, S., Jain, S., & SARKHEL, B. C. (2012) · Animal Biotechnology · doi:10.1080/10495398.2012.664598 · Cited by 8
“The specific toxicity of plasmid= liposome complexes has been previously reported (32, 33).”
BackgroundSokolov, A. V., Limareva, L. V., Iliasov, P. V., Витальевна, Г. О., & Sustretov, A. S. (2021) · Russian Journal of Organic Chemistry · doi:10.1134/s1070428021040011 · Cited by 9
In Vivo GFP Knockdown by Cationic Nanogel-siRNA Polyplexes
Shrivats, A. R., Mishina, Y. M., Averick, S. E., Matyjaszewski, K. A., & Hollinger, J. O. (2015) · Bioengineering · doi:10.3390/bioengineering2030160 · Cited by 8
From RNA Interference Technology to Effective Therapy: How Far have We Come and How Far to go?
Keaney, J., Campbell, M., & Humphries, P. (2011) · Therapeutic Delivery · doi:10.4155/tde.11.109 · Cited by 8
Cheah, H. Y., Kiew, L. V., Lee, H. B., Japundžić‐Žigon, N., Vicent, M. J., Hoe, S.-Z., & Chung, L. Y. (2017) · Journal of Applied Toxicology · doi:10.1002/jat.3437 · Cited by 8
“For the assessment of NSCs, prolonged exposure (96 h postfertilization) of silica NP-induced pericardia toxicity and caused bradycardia (Duan et al., 2013).”
BackgroundLipid-based delivery of CpG oligodeoxynucleotides for cancer immunotherapy
Wilson, K. D., & Tam, Y. K. (2009) · Expert Review of Clinical Pharmacology · doi:10.1586/17512433.2.2.181 · Cited by 7
Nelson, A. D., Shiveshwarkar, P., Lim, B., Rojas, G., Abure, I., Shrestha, A., & Jaworski, J. W. (2020) · Biosensors · doi:10.3390/bios10100132 · Cited by 7
Lipid membrane-based therapeutics and diagnostics
de Carvalho, P. M. B., Makowski, M., Domingues, M. M., Martins, I. C., & Santos, N. C. (2021) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2021.108858 · Cited by 7
Engineered liposomes as drug delivery and imaging agents
Behera, A., Padhi, S., & Nayak, A. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-89953-6.00010-6 · Cited by 7
Preparation and Preliminary Evaluation of Dual-functional Nanoparticles for MRI and siRNA Delivery.
Sun, J., Zhou, Y., Jin, G., Jin, Y. J., & Quan, J. (2021) · PubMed Central · doi:10.22037/ijpr.2021.115099.15219 · Cited by 7
In VivoEvaluation of Acute and Chronic Nanotoxicity
Nehoff, H. L., Parayath, N. N., Taurin, S., & Greish, K. F. (2014) · doi:10.1002/9781118856017.ch3 · Cited by 7
Positive Charge, Negative Effect: The Impact of Cationic Nanoparticles in The Brain
M�ller, P., & Lykkesfeldt, J. (2014) · Nanomedicine · doi:10.2217/nnm.14.91 · Cited by 7
Sundaram, D. N. M., Vij, M., Pandey, T., Natarajan, P., Sharma, R., Mishra, S., & Ganguli, M. (2018) · ACS Biomaterials Science & Engineering · doi:10.1021/acsbiomaterials.8b00069 · Cited by 6
Nano-delivery of Food-Derived Biomolecules: An Overview
Jhala, D., Rather, H., & Vasita, R. (2018) · Springer eBooks · doi:10.1007/978-981-13-1123-9_20 · Cited by 5
Delivery Aspects for Implementing siRNA Therapeutics for Blood Diseases
Dezfouli, S. A., Michailides, M. E., & Uludağ, H. (2024) · Biochemistry · doi:10.1021/acs.biochem.4c00327 · Cited by 5
Farnia, P., Ghanavi, J., Bahrami, A., Bandehpour, M., Kazemi, B., & Velayati, A. A. (2015) · Europe PMC (PubMed Central) · Cited by 5
Toxicity Evaluation of Nanomedicine
Panghal, A., & Flora, S. J. S. (2022) · Springer eBooks · doi:10.1007/978-3-031-12398-6_19 · Cited by 5
Liposomal encapsulation enhances the activity of immunostimulatory oligonucleotides
Tam, Y. K. (2006) · Future Lipidology · doi:10.2217/17460875.1.1.35 · Cited by 5
“Although the toxic nature of these responses is less clear in the context of immunostimulatory applications, such as those described here, they do contribute directly to secondary effects, such as dose-dependent hematologic changes typified by profound leukopenia, thrombocytopenia and neutropenia [40,41] and organ-rel…”
BackgroundSynthesis of Fullerene-Acid Conjugates
Zhang, J., Li, Y., & Zhang, Y. D. (2012) · Advanced materials research · doi:10.4028/www.scientific.net/amr.463-464.538 · Cited by 5
Tao, L.-L., Zhai, Z., Chen, N.-Y., Cheng, Y., & Liu, X.-H. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18020259 · Cited by 4
“However, the potential toxicity of LNPs has been demonstrated to induce abnormal levels of reactive oxygen species (ROS) in vivo, leading to oxidative stress [4,5].”
Smart Telomerase-Gated DNA cage for precise siRNA release in cancer cells
Han, X., Lu, Y., Wu, H., Guan, X., Ma, X., Chu, Y., Zou, B., & Zhou, G. (2023) · Chemical Engineering Journal · doi:10.1016/j.cej.2023.143782 · Cited by 4
Ullah, I., Choi, H. S., Choi, C., Chung, K., Jung, J. W., Yun, G., Heo, S., Yi, Y., Kang, E., Kim, S., et al. (2024) · Biotechnology and Bioprocess Engineering · doi:10.1007/s12257-024-00027-3 · Cited by 4
“Additionally, RVG9R prevents inflammatory responses associated with cationic liposomes, demonstrating its safety [57].”
Simón‐Vázquez, R., Peleteiro, M., Lozano‐Fernández, T., González‐Fernández, Á., & Casal, A. (2012) · Frontiers of nanoscience · doi:10.1016/b978-0-12-415769-9.00015-7 · Cited by 5
Gusachenko, O. N., Pyshnyi, D. V., Vlassov, V. V., & Аркадьевна, З. М. (2008) · Human Gene Therapy · doi:10.1089/hum.2007.049 · Cited by 4
“These include cytotoxicity of lipid-based carriers, immune response to virus-based particles, and so on (Lappalainen et al ., 1994; Filion and Phillips, 1997; Worgall et al ., 1997; Timme et al ., 1998; Nyberg-Hoffman and Aguilar-Cordova, 1999; Dokka et al ., 2000; Raper et al ., 2003).”
Sale, E. J., Satari, M., & Hajipour-Verdom, B. (2025) · ADMET & DMPK · doi:10.5599/admet.3065 · Cited by 3
“Despite this deficiency, anionic liposomes have become of interest as promising gene delivery vehicles due to the disadvantages of cationic liposomes, like inactivation by serum, instability in storage, and in vitro and in vivo cytotoxicity [76, 77].”
Bae, C.-S., & Ahn, T. (2026) · Han-guk hyeonmigyeong hakoeji/Applied microscopy · doi:10.1186/s42649-026-00130-0 · Cited by 4
“Unlike their neutral and negatively charged counterparts, they may induce lung inflammation and toxicity by stimulating the production of ROS (Dokka et al. 2000).”
RNA drugs and nonviral nanocarriers in oncology – present status and emerging concepts
Aigner, A. M. (2025) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2025.152512 · Cited by 3
Joshi, N. (2018) · Current Pathobiology Reports · doi:10.1007/s40139-018-0183-9 · Cited by 3
General justification in terms of effectiveness and toxicities for the use of nanocarriers
Handali, S., & Rezaei, M. (2023) · Journal of Nanoparticle Research · doi:10.1007/s11051-023-05826-y · Cited by 3
“2,2,6,6-Tetramethylpi-peridine-1-oxyl (TEMPO) as a stable nitroxide free radical exhibited antioxidant activity by ROS scavenging.”
BackgroundInfluentialApoptosis induced by cationic liposome based on the mitochondrial signaling pathway in vitro
Du, S., Wang, Y., Li, M., Zhao, Y., Zhi, D., Cui, S., & Zhang, S. (2024) · Journal of Materials Science · doi:10.1007/s10853-024-10192-8 · Cited by 3
“The primary factor contribute to this cytotoxicity is the cationic headgroup [12, 13].”
Yang, B., Mao, J. Y., Jiang, S., Wei, J., Li, Y., Gao, B., & Lu, X. (2019) · Preparative Biochemistry & Biotechnology · doi:10.1080/10826068.2019.1591979 · Cited by 3
“It has also been reported that the positive charge of the liposomes is a key factor of toxicity, with some studies using mice to test differently charged liposomes including Lipofectamine, DOTAP, neutral and negatively charged liposomes.([13]) It has been demonstrated in the previous study that the cationic liposomes…”
BackgroundPérez, S. E., Gándola, Y. B., Carlucci, A. M., & González, L. (2015) · Journal of Nanoparticle Research · doi:10.1007/s11051-015-2937-1 · Cited by 3
“…strong interaction with blood components, uptake by the reticuloendothelial system (RES), targeting-related issues, and potential toxicity for lung and other organs were associated with the use of these delivery systems (Dokka et al. 2000; Spagnou et al. 2004; Lv et al. 2006; Guo and Huang 2012).”
BackgroundIntratracheal Instillation of Lipopolymeric Vectors and the Effect on Mice Lung Physiology
Xisto, D. G., Temprana, C. F., Martini, S. V., da Silva, A. L., Abreu, S. C., Silva, J. D., Crosseti, J., Rocco, P. R. M., Alonso, S. D. V., & Morales, M. M. (2012) · Cellular Physiology and Biochemistry · doi:10.1159/000336917 · Cited by 3
Can Nanotechnology Hit the Spot in aerosol-based Drug Delivery for Lung disorders?
Joshi, N. (2018) · Therapeutic Delivery · doi:10.4155/tde-2017-0112 · Cited by 3
Saving zone of stasis in burn wounds by nanoliposomal Mg‐ATP
Hayati, F., Ghamsari, S. M., Dehghan, M. M., & Hamid, T. (2022) · Wound Repair and Regeneration · doi:10.1111/wrr.13048 · Cited by 2
“encapsulation of Mg-ATP, a negatively charged molecule, DOTAP might be used in the nanoliposome structure, but there have been claims that cationic liposomes are cytotoxic due to interactions between positively charged lipids and cell organelle membranes.(31,32) It is also accepted that anionic liposomes are less toxi…”
BackgroundInnovative siRNA Strategies: Scaling New Horizons in Diabetic Foot Ulcer Therapeutics
Kolipaka, T., Pandey, G., Amulya, E., Singh, A. K., Srinivasarao, D. A., & Srivastava, S. K. (2026) · BioNanoScience · doi:10.1007/s12668-025-02389-1 · Cited by 2
“[96, 97] Polymeric System Particle size and Shape Structural Chemistry • Immunogenic response • The branched chains are more toxic compared to the lin - ear ones.”
Feng, Y., Zhao, Y., Han, J., Li, F., Li, G., Wang, B., Chen, Q., & Song, J. (2026) · Nano Research · doi:10.26599/nr.2026.94908571 · Cited by 3
Functionalized lipoplexes and polyplexes for cancer therapy
Chhikara, N., Singh, J., Sharma, A., Sood, A., & Kumar, A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-15518-5.00006-9 · Cited by 2
Zheng, D., Lu, Z. G., Li, J., Dong, J., Zhang, X., Zhang, X., & Cao, D. (2025) · The Journal of Physical Chemistry B · doi:10.1021/acs.jpcb.4c07520 · Cited by 2
Pharmacogenomics-based RNA interference nanodelivery: focus on solid malignant tumors
Rosen, Y., Upadhyay, U. M., & Elman, N. M. (2012) · Expert Opinion on Drug Delivery · doi:10.1517/17425247.2012.685932 · Cited by 2
“Cationic liposomes can activate complement, induce production of factors such as tumor necrosis factor-a, and interleukin-6 and -12 [1,62,63].”
BackgroundAdvances on nucleic acid delivery with nonviral vectors
Lopes, R. M., Fonseca, N. A., Cruz, A. F., Gregório, A. C., Valério-Fernandes, Â., Moura, V., Simões, S., & Moreira, J. N. (2016) · Elsevier eBooks · doi:10.1016/b978-0-08-100741-9.00014-0 · Cited by 2
Yun, C., Bae, C., & Ahn, T. (2018) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-018-9674-0 · Cited by 2
Lipid-Based Nanosystems for the Delivery of siRNA: Challenges and Trends
Fonseca, N. A., Lopes, R. M., Cruz, A. F., Gregório, A. C., Valério-Fernandes, Â., Moura, V., Simões, S., & Moreira, J. N. (2018) · Elsevier eBooks · doi:10.1016/b978-0-12-813339-2.00016-5 · Cited by 3
Metadata
- Authors
- Dokka, S., Toledo, D., Shi, X., Castranova, V., & Rojanasakul, Y.
- Affiliations
- West Virginia University (US)
- National Institute for Occupational Safety and Health (US)
- Corresponding author
- Rojanasakul, Yon
- Venue
- Pharmaceutical Research
- Published
- 2000-05
- Volume
- 17
- Issue
- 5
- Pages
- 521-525
- ISSN
- 0724-8741 (ISSN-L)
- 1573-904X
- OpenAlex
- W1580639099
- Cited by
- 349
- References
- 14
- Citations by year
- 2026: 12 · 2025: 8 · 2024: 19 · 2023: 25 · 2022: 17 · 2021: 18 · 2020: 6 · 2019: 16 · 2018: 19 · 2017: 17 · 2016: 17 · 2015: 26 · 2014: 21 · 2013: 19 · 2012: 18
- FWCI
- 2.92
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Pharmaceutical Research (publishedVersion)
- PubMed (publishedVersion)
- Funders
- West Virginia University
- National Institutes of Health (1r15hl062959-01)
- National Heart, Lung, and Blood Institute (HL-62959)
- National Institute for Occupational Safety and Health
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Inhalation and Respiratory Drug Delivery
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- cationic liposomes, pulmonary toxicity, reactive oxygen species, lipofectamine, DOTAP, liposome charge, respiratory burst, lung inflammation, liposomal gene delivery, chemiluminescence
- MeSH terms
- Animals, Bronchoalveolar Lavage Fluid, Cations, Cyclic N-Oxides, L-Lactate Dehydrogenase, Liposomes, Luminescent Measurements, Lung Diseases, Male, Mice, Inbred BALB C, Nitrogen Oxides, Free Radical Scavengers, Reactive Oxygen Species, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review